Abstract Session I (CONG2017-07)

This activity includes the following:

Reflux is underestimated in patients with suspected deep venous obstruction
  Christopher Lattimer, PhD

Lymphatic contribution to progressive peripheral venous and arterial disease and ulceration
  John Rasmussen, PhD

Vulval Varicose Veins - Associations with Pelvic Vein Reflux and Parity
  Charlotte Davies, BSc

Medical compression stockings or leg elevation significantly reduce apoptosis compared to standing
  Christopher Lattimer, PhD

Moving Towards a Wireless, Battery-Less, and Soft Interface Pressure Sensor for Continuous Use: Mechanically Modeling the Effect of Encapsulation Thickness and Geometry
  Shuai Xu, MD, MSc

Persistent aggregates at the valve sinus are different from sludge or thrombus. A pilot study on HR ultrasound findings.
  Johann Christof Ragg, MD

Duplex ultrasound for diagnosis of the Popliteal Vein entrapment syndrome
  Julie Mason, RVT

Evaluation of Aberdeen Varicose Vein Questionnaire as a tool to evaluate aesthetic outcomes in C1 patients
  Fabricio Santiago, MD, MSc

Tissue texture and limb circumference affect overall interface pressure measurement during compression therapy
  Yung-Wei Chi, DO, FACPh, RPVI, RVT

New Monopolar Radiofrequency Ablation for Incompetent Saphenous Veins Compared with Conventional Bipolar Catheter
  Naoki Sakakibara, MD, PhD

POWER and LEED, not pull back rate, are the key determinants of long term success in Endovenous Laser Ablation (EVLA) of the truncal saphenous veins: A prospective study of endovenous laser ablation using the 1470-nm jacket tip Angiodynamics Never TouchTM laser fiber in 2013 consecutive patients
  Sanjay Srivatsa, MD, FACC, FACP

Cyanoacrylate Closure of Incompetent Great, Small and Accessory Saphenous Veins without the use of Post-Procedure Compression: a Post-Market Evaluation of the VenaSeal System (WAVES trial): Twelve Month Data
  Kathleen Gibson, MD

Comparison of endovenous radiofrequency ablation, laser ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT.
  Lars Rasmussen, MD

Steps to Successfully Complete This Activity

To participate in this educational activity please follow the steps listed below.

If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.

  1. To begin the activity click the START COURSE button.
  2. Progress through course content by using the NEXT button.
  3. Complete all required items in the course.
  4. Track your progress using the Course Progress menu.
  5. On the final page of the activity a link will be provided to download your certificate.

Target Audience

The primary target audience includes physicians, physician assistants and advanced registered nurse practitioners, ultrasound technologists, nurses, allied health and all other healthcare professionals currently or planning to care for patients with venous disease. Specialists focusing on phlebology, cardiology, general surgery, vascular surgery, interventional radiology, interventional cardiology, dermatology, dermatologic surgery, internal medicine, family practice, plastic surgery, obstetrics and gynecology, vascular medicine, and emergency medicine are invited to enhance their knowledge and skills specific to the treatment of venous and lymphatic disease.

Course summary
Course opens: 
Course expires: 
NameRoleCommercial InterestType of Relationship
Yung-Wei Chi, DO, FACPh, RPVI, RVTSpeakerVenoSense, Inc.Board Member; Shareholder
Charlotte Davies, BScSpeakerNonen/a
Sergio Gianesini, MD, PhDPlanner; ModeratorNonen/a
Kathleen Gibson, MDSpeaker

1. Medtronic

2. BTG

3. Angiodynamics

4. Bayer

5. Bristol Myers Squibb

6. Vascular Solutions

1. Consultant; Research Support

2. Consultant

3. Research Support

4. Research Support

5. Speaker's Bureau

6. Speaker

Christopher Lattimer, PhDSpeaker

1. Bauerfeind

2. Sigvaris

3. Servier

4. Firstkind

1. Consultant

2. Funder of project on endogenous biomarkers

3. Consultant

4. Consultant

Julie Mason, RVTSpeakerNonen/a
Stephen H. Moss, BA, CHCPStaffNonen/a
Joseph Raffetto, MD, FACS, FSVMModeratorNonen/a
Johann Christof Ragg, MDSpeakerNonen/a
John Rasmussen, PhDSpeakerNIRF Imaging, Inc.Consultant; Stockholder
Lars Rasmussen, MDSpeakerNonen/a
Naoki Sakakibara, MD, PhDSpeakerNonen/a
Fabricio Santiago, MD, MScSpeakerNonen/a
Sanjay Srivatsa, MD, FACC, FACPSpeakerNonen/a
Shuai Xu, MD, MScSpeakerNorthwestern UniversityPatent Inventor



The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.


Discussion of Off-Label Use

Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.


Reproduction Prohibited

Reproduction of this material is not permitted without the express written permission from the copyright owner.


Please login or register to take this course.